Plant compounds in spices like turmeric and garlic may help prevent cell damage, manage cholesterol, and provide other health ...
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) said it has launched a placebo-controlled Phase 1b proof-of-concept ...
Mesoblast says FDA feedback supports filing plans for its cell therapy to treat chronic back pain, showing reduced pain and ...
An initial 6-week course of intranasal saline resolved symptoms for 29.5% of 3- to 12-year-olds with obstructive ...
The initiation of patient enrolment in the STARS DAPT trial marks an important milestone for Abluminus np. While contemporary ...
Introduction The increasing incidence of type 2 diabetes mellitus (T2DM) among women of reproductive age poses significant health risks for both mothers and their fetuses. Optimising blood glucose ...
Background Foodborne diseases are an important cause of global morbidity and mortality, particularly among children who often ...
SPARK NS and Haukeland University Hospital today announced they are collaborating on a randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the efficacy of orally administered ...
4d
HHS Gave a $1.6 Million Grant to a Controversial Vaccine Study. These Emails Show How That Happened
Two Danish researchers faced accusations of “questionable research practices” as RFK Jr.’s top appointees made their study a “funding priority.” ...
At Stanford, a treatment that aims magnetic pulses at the brain is showing results for people with treatment-resistant depression. It’s called SAINT, and here’s how it works.
In sweeping changes to the childhood vaccine schedule, the Centers for Disease Control and Prevention no longer recommends ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback